Search - tctmd.com

Displaying 341 - 349 of 349

Presentation TCT 2012

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

Presenter: Brijeshwar Maini, William O?Neill, Simon Dixon, Igor Palacios, Theodore Schreiber, David A. Gregory, D. J. Scotti

January 03, 2012

News Conference News

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Conference News

PROTECT II: Positive Outcomes Observed with Impella Device

November 08, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Conference News

Debate: PCI vs. CABG for Left Main Disease

November 07, 2011

Video

» Live Case

LIVE Case Providence St. Vincent Hospital, Portland, OR - MCS-Supported High-Risk PCI With IVUS Guidance (PROTECT 4)

November 8, 2023

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Usman Baber About the TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

September 27, 2019

Advertisement

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

PROTECT II: Positive Outcomes Observed with Impella Device

Ongoing Trials Explore Potential Benefits of Transradial PCI

Debate: PCI vs. CABG for Left Main Disease

LIVE Case Providence St. Vincent Hospital, Portland, OR - MCS-Supported High-Risk PCI With IVUS Guidance (PROTECT 4)

Dr. C. Michael Gibson Talks With Dr. Usman Baber About the TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content